● LIVE
NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40
Login☆ Watchlist
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommoditiesIPOs
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingStartupsEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth

LUPIN

BSE
F&O
Lupin Limited
Healthcare· Pharmaceuticals & Biotechnology· INE326A01037· Scrip: 500257
ENहिन्दीગુજરાતીमराठी
2,248.70
14.70 (+0.00%)
2026-06-10
BSE
2,248.70
14.70
+0.00%
1,8432,0002,1572,3152,47206-1908-1210-0812-0301-2903-2706-0306-10
230 trading days · 1Y period
TODAY (BSE)
Open2,263.40
High2,280.00
Low2,242.40
Prev Close2,263.40
Volume16,969
Value₹3.8Cr
L: 2,242.40H: 2,280.00
Info
Face Value₹2
Listed2001-09-10
ISININE326A01037
SeriesA
BSE Scrip500257

Key Metrics

1D
1W
1M
3M
6M
Growth (QoQ)
Revenue+1.67%
PAT-0.07%
EPS+0.27%
Profitability
Dividend
Growth+50.00%
TTM Revenue
₹20569 Cr
TTM EBITDA
₹5580 Cr
TTM PAT
₹2976 Cr
TTM EPS
₹64.85
Rev/Share
₹449.9

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr1442 Cr2884 Cr4326 Cr5768 Cr22-1223-0323-0923-1224-0324-0624-0924-123.45.210.813.57.919.518.718.8
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-315768 Cr4750 Cr1622 Cr1071 Cr859 Cr18.75
2024-09-305673 Cr4660 Cr1578 Cr1055 Cr859 Cr18.70
2024-06-304168 Cr3123 Cr1224 Cr1083 Cr889 Cr19.51
2024-03-314961 Cr4492 Cr1156 Cr498 Cr368 Cr7.89
2023-12-315197 Cr4491 Cr1185 Cr736 Cr619 Cr13.47
2023-09-305039 Cr4449 Cr1093 Cr630 Cr495 Cr10.76
2023-03-314430 Cr4209 Cr631 Cr259 Cr242 Cr5.19
2022-12-314322 Cr4094 Cr639 Cr246 Cr158 Cr3.38

Shareholding Pattern

CURRENT2026-03-31
46.9%PROMOTER
Promoter46.9%
FII21.7%
DII25.3%
Public53.1%
PROMOTER HOLDING TREND
47.0%24-0647.0%24-0947.0%24-1246.9%25-0346.9%25-0946.9%25-1246.9%26-03

Corporate Actions

Ex-DateTypePurpose
2025-07-25DividendDividend - Rs 12 Per Share
2024-07-16DividendDividend - Rs 8 Per Share
2023-07-14DividendDividend - Rs 4 Per Share
2022-07-14DividendDividend - Rs 4 Per Share
2021-07-27Dividend Dividend - Rs 6.50 Per Share
2020-08-03Dividend Annual General Meeting/Dividend - Rs 6 Per Share
2019-07-29Dividend Annual General Meeting/Dividend - Rs 5 Per Share
2018-07-30Dividend Annual General Meeting/Dividend Rs 5/- Per Share
2017-07-24Dividend Annual General Meeting/Dividend - Rs 7.50 Per Share
2016-07-25Dividend Annual General Meeting/ Dividend -Rs 7.50/- Per Share
2015-07-14DividendAnnual General Meeting/ Dividend - Rs 7.50/- Per Share
2014-07-21DividendAnnual General Meeting / Final Dividend - Rs 3/- Per Share
2014-02-13DividendInterim Dividend - Rs 3/- Per Share
2013-07-29DividendAnnual General Meeting / Dividend - Rs 4/- Per Share
2012-07-13DividendAnnual General Meeting And Dividend Rs.3.20 Per Share
2011-07-18DividendAnnual General Meeting And Dividend Rs.3/- Per Share
2010-08-27SplitFace Value Split From Rs.10/- To Rs.2/-
2010-07-19DividendAnnual General Meeting And Dividend Rs.13.50 Per Share
2009-07-20OtherAgm/Div-Rs.12.50 Pr Share
2008-07-11OtherAgm/Div-50% + Spl Div-50%

Earnings Transcripts

Price History

DateOpenHighLowCloseVolume
2026-06-102,264.202,280.502,242.102,247.207.35L
2026-06-032,248.602,265.002,235.002,261.205.70L
2026-05-272,258.302,292.202,250.502,276.405.69L
2026-05-262,287.202,294.002,250.002,266.008.89L
2026-05-252,294.002,294.002,269.802,287.207.74L
2026-05-222,297.002,304.502,270.002,281.8012.25L
2026-05-212,297.102,304.302,269.602,284.5012.24L
2026-05-202,275.102,309.602,264.802,285.5011.90L
2026-05-192,252.402,294.002,250.502,287.4012.43L
2026-05-182,240.002,274.902,214.102,252.409.07L
2026-05-152,268.002,299.002,254.102,276.2020.60L
2026-05-142,248.002,273.802,225.002,258.2014.53L
2026-05-132,245.802,267.202,210.602,215.6013.24L
2026-05-122,256.002,289.802,233.002,245.4014.13L
2026-05-112,330.402,330.402,236.102,255.9032.79L
2026-05-082,425.002,475.002,347.902,379.5032.07L
2026-05-072,454.902,494.002,430.402,460.1014.10L
2026-05-062,362.302,459.002,350.402,442.9028.86L
2026-05-052,354.002,364.602,326.602,343.3014.19L
2026-05-042,320.002,361.902,304.102,348.8013.05L
2026-04-302,297.002,317.402,277.702,305.2010.96L
2026-04-292,314.002,333.802,302.702,311.407.07L
2026-04-282,299.102,319.402,260.302,302.7012.62L
2026-04-272,304.902,341.002,296.202,324.508.99L
2026-04-242,347.302,351.502,262.002,296.1012.99L
2026-04-232,307.902,381.002,293.902,341.4011.16L
2026-04-222,304.702,318.602,285.102,307.909.89L
2026-04-212,333.002,340.202,304.002,311.505.28L
2026-04-202,323.002,339.302,303.702,328.707.20L
2026-04-172,316.002,335.002,300.002,326.1010.00L

Frequently Asked Questions

About

Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai, specializing in developing, manufacturing, and marketing a wide range of generic and specialty medicines. Key products include cardiovascular, central nervous system, and oncology drugs, with a significant presence in global markets. Notably, the company was founded in 1937 by Dr. C. S. I. Devanand and has grown to become a leading player in the pharmaceutical industry, particularly in the United States.

BOARD OF DIRECTORS
Vinita Gupta
Whole-time Director
Alfonso Zulueta
Independent Director
Anand Kripalu
Independent Director
Christine Mundkur
Independent Director
DEPARTED
Robert Funsten
Independent Director
Punita Lal
Additional Director

Mutual Fund Holdings

5 funds · bar length = % to NAVBrowse all funds →
hdfc2 schemes
HDFC NIFTY MIDCAP 150 INDEX FUND
1.60%
₹8 Cr
HDFC Large and Mid Cap Fund
1.28%
₹3.2K Cr
capitalmind1 scheme
Capitalmind Mutual Fund
1.26%
₹5 Cr
baroda2 schemes
Baroda BNP Paribas Health and Wellness Fund
0.06%
₹32 Cr
Baroda BNP Paribas NIFTY Midcap 150 Index Fund
0.02%
₹0 Cr